It was a tumultuous week in the markets, with US indexes losing between 15% and 18%. Shanghai was also negative, after its week of vacation, droppin...
I could easily blog about how badly biopharma is performing in this bear market, how all of the big pharma stocks hit new lows this morning with the l...
I could easily blog about how badly biopharma is performing in this bear market, how all of the big pharma stocks hit new lows this morning with the l...
Photo courtesy of iStockphoto, Andrey ProkhorovThe European Molecular Biology Organization (EMBO)will launch a new journal focusing on the interface b...
History has shown again and again that times like these represent a huge long-term buying opportunity. This may be particularly true for the biotech s...
History has shown again and again that times like these represent a huge long-term buying opportunity. This may be particularly true for the biotech s...
Photo courtesy of iStockphoto, Michal KoziarskiCornell University researchers have tested 25 fruits of its cellular antioxidant activity (CAA) and fou...
Lev Pharmaceuticals (LEVP.OB) is a biotechnology company, which has focused on developing a treatment for the serious, and potentially life-threatenin...
Although the third quarter of this year was one of the more downbeat ones, there are still some ETFs that managed to post gains amid the wreckage.Doug...
Okay, what were the chances that ImClone (IMCL) would get bought and Dendreon (DNDN) would come out with its interim test results on the same morning?...
Jeff Matthews Is Not Making This Up The World of Wall Street in all its glory, and anything else that strikes our fancy. Informed observations about comp...
Stock Market Beat Our beat is the stock market. Our job is to beat it....
TechCrunch TechCrunch profiles the companies, products and events that are defining and transforming the new web. TechCrunch is ...
Trader Mike Stock market commentary & trading ideas. Stock market weblog (blog), swing trading, day trading, stock picks, techni...
Subscribe On Your Mobile
Subscribe
.gif)
Environmental Economics
Paul Kedrosky's Infectious Greed
Jeff Matthews Is Not Making This Up
TechCrunch
Trader Mike
